SCHEMBL29958517

SCHEMBL29958517

O=S(=O)(C(=Cc1cccc(Cl)c1)S(=O)(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 2/20 0.50
▸ MAOB P27338 1/20 0.49
▸ KDM4E B2RXH2 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ POLB P06746 2/20 0.47
▸ PKM P14618 2/20 0.47
▸ FBP1 P09467 1/20 0.46
▸ PGR P06401 3/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ MEN1 O00255 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ MDM4 O15151 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ MDM2 Q00987 1/20 0.41
▸ AKR1C2 P52895 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27033790 1.00 AKR1C3 (0.50) AKR1C3MAOBKDM4EALDH1A1KMT2A
SCHEMBL28595702 0.84 AKR1C3 (0.48) AKR1C3MAOBKDM4EALDH1A1KMT2A
SCHEMBL29289244 0.81 ALDH1A1 (0.65) AKR1C3KDM4EALDH1A1KMT2APOLB
SCHEMBL29289242 0.81 ALDH1A1 (0.65) AKR1C3KDM4EALDH1A1KMT2APOLB
SCHEMBL29178129 0.72 NFE2L2 (0.61) MAOBCYP1A2CYP2C9NFE2L2
SCHEMBL29178131 0.72 NFE2L2 (0.61) MAOBCYP1A2CYP2C9NFE2L2
SCHEMBL6333516 0.72 FBP1 (0.54) AKR1C3MAOBKDM4EALDH1A1KMT2A
SCHEMBL6333513 0.72 FBP1 (0.54) AKR1C3MAOBKDM4EALDH1A1KMT2A
SCHEMBL28210065 0.71 TSHR (0.70) KDM4EALDH1A1KMT2APOLBFBP1
SCHEMBL10731566 0.71 PGR (0.41) ALDH1A1KMT2AFBP1PGRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308228-A1 PLASMA KALLIKREIN INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2024-01-24 — — EP disclosed
CN-117396474-A Plasma kallikrein inhibitors 武田药品工业株式会社 2024-01-12 — — CN disclosed
WO-2022197756-A1 PLASMA KALLIKREIN INHIBITORS SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 — — WO disclosed
Send feedback